82
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection

, ORCID Icon, , , , , , , , , , , , & show all
Pages 4267-4282 | Published online: 30 Aug 2021

References

  • Senobar Tahaei SA, Stájer A, Barrak I, et al. Correlation between biofilm-formation and the antibiotic resistant phenotype in staphylococcus aureus isolates: a Laboratory-Based Study in Hungary and a review of the literature. Infect Drug Resist. 2021;14:1155–1168. doi:10.2147/IDR.S303992
  • Gajdács M, Urbán E. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(4):143–147.
  • Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015;386(9998):1097–1108. doi:10.1016/S0140-6736(15)60733-4
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55.
  • Davis JS, Van Hal S, Tong SY. Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections. Semin Respir Crit Care Med. 2015;36(1):3–16. doi:10.1055/s-0034-1396906
  • Gajdács M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019;8(2):52. doi:10.3390/antibiotics8020052
  • Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9(12):894–896. doi:10.1038/nrmicro2693
  • Beibei L, Yun C, Mengli C, et al. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2010;35(1):3–12. doi:10.1016/j.ijantimicag.2009.09.013
  • Conaughty JM, Chen J, Martinez OV, et al. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model. Spine. 2006;31(22):E830–E832. doi:10.1097/01.brs.0000241065.19723.13
  • Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892. doi:10.3390/molecules24050892
  • Aslam A, Gajdács M, Zin CS, et al. Evidence of the practice of self-medication with antibiotics among the lay public in low- and middle-income countries: a scoping review. Antibiotics. 2020;9(9):597. doi:10.3390/antibiotics9090597
  • Shopsin B, Kaveri S, Bayry J. Tackling difficult Staphylococcus aureus infections: antibodies show the way. Cell Host Microbe. 2016;20(5):555–557. doi:10.1016/j.chom.2016.10.018
  • Correia B, Bates JT, Loomis RJ, et al. Proof of principle for epitope-focused vaccine design. Nature. 2014;507(7491):201–206. doi:10.1038/nature12966
  • Akram A, Inman R. Immunodominance: a pivotal principle in host response to viral infections. Clin Immunol. 2012;143(2):99–115. doi:10.1016/j.clim.2012.01.015
  • Kilpatrick K, Wring SA, Walker DH, et al. Rapid development of affinity matured monoclonal antibodies using RIMMS. Hybridoma. 1997;16(4):381–389. doi:10.1089/hyb.1997.16.381
  • Zhao Z, Zhang J, Song X, et al. An immunodominant epitope-specific monoclonal antibody cocktail improves survival in a mouse model of Staphylococcus aureus bacteremia. J Infect Dis. 2021;223(10):1743–1752.
  • Chen Z, Gou Q, Xiong Q, et al. Immunodominance of epitopes and protective efficacy of HI antigen are differentially altered using different adjuvants in a mouse model of Staphylococcus aureus bacteremia. Front Immunol. 2021;12:684823. doi:10.3389/fimmu.2021.684823
  • Hua L, Hilliard JJ, Shi Y, et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother. 2014;58(2):1108–1117. doi:10.1128/AAC.02190-13
  • Zhang J, Yang F, Zhang X, et al. Protective efficacy and mechanism of passive immunization with polyclonal antibodies in a sepsis model of Staphylococcus aureus infection. Sci Rep. 2015;5(1):15553. doi:10.1038/srep15553
  • Bhakdi S, Jursch R, Bröker M, et al. Functionally inactive S. aureus alpha-toxin containing a single amino acid substitution: potential usefulness as a vaccine. Behring Inst Mitt. 1994;95:80–84.
  • Zhao Z, Sun H-Q, Wei -S-S, et al. Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection. Sci Rep. 2015;5(1):12371. doi:10.1038/srep12371
  • Rieder S, Nagarkatti P, Nagarkatti M, Bliska JB. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury. Infect Immun. 2011;79(8):3141–3148. doi:10.1128/IAI.00177-11
  • Krakauer T, Buckley M, Fisher D. Murine models of staphylococcal enterotoxin B-induced toxic shock. Mil Med. 2010;175(11):917–922. doi:10.7205/MILMED-D-10-00148
  • Sanders ME, Taylor S, Tullos N, et al. Passive immunization with Pneumovax®23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. BMC Ophthalmol. 2013;13(1):8. doi:10.1186/1471-2415-13-8
  • Salinas E, Boisvert M, Upadhyay AA, et al. Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion. J Clin Invest. 2021;131(2):e140590. doi:10.1172/JCI140590
  • Domenech M, Sempere J, de Miguel S, et al. Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract. Front Immunol. 2018;9:2700. doi:10.3389/fimmu.2018.02700
  • Ramos-Sevillano E, Rodríguez-Sosa C, Díez-Martínez R, et al. Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism. Antimicrob Agents Chemother. 2012;56(11):5534–5540. doi:10.1128/AAC.01470-12
  • Cafini F, Yuste J, Giménez M-J, et al. Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model. PLoS One. 2010;5(8):e12041. doi:10.1371/journal.pone.0012041
  • Krakauer T, Pradhan K, Stiles B. Staphylococcal superantigens spark host-mediated danger signals. Front Immunol. 2016;7:23. doi:10.3389/fimmu.2016.00023
  • Varshney AK, Wang X, Scharff MD, et al. Staphylococcal enterotoxin B–specific monoclonal antibody 20b1 successfully treats diverse Staphylococcus aureus Infections. J Infect Dis. 2013;208(12):2058–2066. doi:10.1093/infdis/jit421
  • von Hoven G, Qin Q, Neukirch C, Husmann M, Hellmann N. Staphylococcus aureus α-toxin: small pore, large consequences. Biol Chem. 2019;400(10):1261–1276.
  • Francois B, Mercier E, Gonzalez C, et al. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial. Intensive Care Med. 2018;44(11):1787–1796. doi:10.1007/s00134-018-5229-2
  • Mazmanian SK, Skaar EP, Gaspar AH, et al. Passage of heme iron across the envelope of Staphylococcus aureus. Science. 2003;299:906–909. doi:10.1126/science.1081147
  • Ebert T, Smith S, Pancari G, et al. A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Hum Antibodies. 2010;19(4):113–128. doi:10.3233/HAB-2010-0235
  • Miller L, Fowler VG Jr, Shukla SK, Rose WE, Proctor RA. Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol Rev. 2020;44(1):123–153.
  • Holden MT, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 2004;101(26):9786–9791. doi:10.1073/pnas.0402521101
  • Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98. doi:10.2146/ajhp080434
  • Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012;54(5):621–629. doi:10.1093/cid/cir895
  • Rose WE, Eickhoff JC, Shukla SK, et al. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis. 2012;206(10):1604–1611. doi:10.1093/infdis/jis552
  • Chantratita N, Tandhavanant S, Seal S, et al. TLR4 genetic variation is associated with inflammatory responses in gram-positive sepsis. Clin Microbiol Infect. 2017;23(1):47.e1–47.e10. doi:10.1016/j.cmi.2016.08.028
  • Rose WE, Shukla SK, Berti AD, et al. Increased endovascular Staphylococcus aureus inoculum is the link between elevated serum interleukin 10 concentrations and mortality in patients with bacteremia. Clin Infect Dis. 2017;64(10):1406–1412. doi:10.1093/cid/cix157
  • Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
  • Lin L, Ibrahim AS, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009;5(12):e1000703. doi:10.1371/journal.ppat.1000703
  • Minejima E, Bensman J, She RC, et al. A dysregulated balance of proinflammatory and anti-inflammatory host cytokine response early during therapy predicts persistence and mortality in Staphylococcus aureus bacteremia. Crit Care Med. 2016;44(4):671–679. doi:10.1097/CCM.0000000000001465
  • Bagnoli F. Staphylococcus aureus toxin antibodies: good companions of antibiotics and vaccines. Virulence. 2017;8(7):1037–1042. doi:10.1080/21505594.2017.1295205
  • Proctor RA. Immunity to Staphylococcus aureus: implications for vaccine development. Microbiol Spectr. 2019;7(4):4–7.
  • Gaudin CFM, Grigg JC, Arrieta AL, Murphy ME. Unique heme-iron coordination by the hemoglobin receptor IsdB of Staphylococcus aureus. Biochemistry. 2011;50(24):5443–5452. doi:10.1021/bi200369p
  • Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence. 2013;4(8):759–773. doi:10.4161/viru.23905